Intraperitoneal nivolumab in a patient with pancreatic cancer and refractory malignant ascites

Sing-Ting Wang1, Chang-Fang Chiu2, Hui-Jen Bai3

  • 1Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, 40402, Taiwan.

European Journal of Cancer (Oxford, England : 1990)
|March 18, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos